SELECTA BIOSCIENCES INC's ticker is SELB and the CUSIP is 816212104. A total of 80 filers reported holding SELECTA BIOSCIENCES INC in Q3 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $189,879 | -8.4% | 179,131 | -3.3% | 0.12% | -2.5% |
| Q2 2023 | $207,389 | -21.0% | 185,169 | -2.0% | 0.12% | -27.4% |
| Q1 2023 | $262,518 | +31.1% | 188,862 | +6.6% | 0.16% | +24.2% |
| Q4 2022 | $200,216 | -38.8% | 177,182 | -11.0% | 0.13% | -42.4% |
| Q3 2022 | $327,000 | +25.8% | 199,137 | +0.3% | 0.23% | +31.6% |
| Q2 2022 | $260,000 | +6.6% | 198,625 | +0.0% | 0.17% | +30.8% |
| Q1 2022 | $244,000 | -61.1% | 198,537 | +3.0% | 0.13% | -57.2% |
| Q4 2021 | $628,000 | -21.6% | 192,718 | +0.1% | 0.31% | -25.1% |
| Q3 2021 | $801,000 | -0.2% | 192,524 | +0.3% | 0.42% | +2.5% |
| Q2 2021 | $803,000 | -9.7% | 192,043 | -2.3% | 0.40% | -13.8% |
| Q1 2021 | $889,000 | +50.7% | 196,555 | +0.9% | 0.47% | +36.2% |
| Q4 2020 | $590,000 | +19.0% | 194,755 | -2.7% | 0.34% | -2.8% |
| Q3 2020 | $496,000 | -13.0% | 200,121 | -0.2% | 0.36% | -20.0% |
| Q2 2020 | $570,000 | +185.0% | 200,588 | +142.0% | 0.44% | +122.0% |
| Q1 2020 | $200,000 | – | 82,900 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 1,627,527 | $29,702,000 | 25.53% |
| Vivo Capital, LLC | 1,119,189 | $20,425,000 | 4.13% |
| GREAT POINT PARTNERS LLC | 901,847 | $16,459,000 | 3.20% |
| Silver Rock Financial LP | 677,025 | $12,356,000 | 1.65% |
| HAMILTON LANE ADVISORS LLC | 91,125 | $1,663,000 | 1.14% |
| Perceptive Advisors | 2,324,650 | $42,424,000 | 0.81% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 951,629 | $17,367,000 | 0.78% |
| Opaleye Management Inc. | 95,000 | $1,733,000 | 0.61% |
| SPHERA FUNDS MANAGEMENT LTD. | 228,534 | $4,171,000 | 0.60% |
| Orbimed Advisors | 1,842,797 | $33,631,000 | 0.32% |